Clinical and genetic findings in a series of Italian children with pure hereditary spastic paraplegia

R. Battini, A. Fogli, D. Borghetti, A. Michelucci, S. Perazza, F. Baldinotti, M. E. Conidi, M. I. Ferreri, P. Simi, G. Cioni

Research output: Contribution to journalArticle

Abstract

Background: Hereditary spastic paraplegias (HSP) are a group of neurodegenerative disorders characterized by progressive lower extremity spastic weakness. SPG7, SPG4 and SPG3A are some of the autosomal genes recently found as mutated in recessive or dominant forms of HSP in childhood. SPG31 is more often associated with a pure spastic paraplegia phenotype, but genotype-phenotype correlation is still unclear. The aims of the current study was: (i) to verify the mutational frequency of SPG4, SPG3A, SPG31 and SPG7 genes in our very-well-selected childhood sample, and (ii) to improve our knowledge about the clinical and electrophysiological HSP phenotypes and their possible correlation with a specific mutation.Methods: A sample of 14 Italian children affected by pure HSP (mean age at diagnosis 5.9 years) was extensively investigated with electrophysiological, neuroradiological and genetic tests.Results: Three SPG4 mutations were identified in three patients: two novel missense mutations, both sporadic, and one multiexonic deletion already reported. A novel large deletion in SPG31 gene involving exons 2-5 was also detected in one young patient. No mutations in the SPG7 and in the SPG3A genes were found.Conclusions: Our data confirm that HSP represent a heterogeneous group of genetic neurodegenerative disorders, also in sporadic or autosomal recessive early onset forms. Multiplex Ligation-dependent Probe Amplification-based mutation screening for SPG4 and SPG31 genes would be added to sequencing-based screening of SPG4, SPG31 and SPG3A genes in the routine diagnosis of HSP children.

Original languageEnglish
Pages (from-to)150-157
Number of pages8
JournalEuropean Journal of Neurology
Volume18
Issue number1
DOIs
Publication statusPublished - Jan 2011

Fingerprint

Hereditary Spastic Paraplegia
Genes
Mutation
Neurodegenerative Diseases
Spastic Paraparesis
Phenotype
Inborn Genetic Diseases
Paraplegia
Multiplex Polymerase Chain Reaction
Genetic Association Studies
Missense Mutation
Exons

Keywords

  • Evoked potentials
  • Gene alterations
  • Pure spastic paraplegia
  • Transcranial magnetic stimulation

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Clinical and genetic findings in a series of Italian children with pure hereditary spastic paraplegia. / Battini, R.; Fogli, A.; Borghetti, D.; Michelucci, A.; Perazza, S.; Baldinotti, F.; Conidi, M. E.; Ferreri, M. I.; Simi, P.; Cioni, G.

In: European Journal of Neurology, Vol. 18, No. 1, 01.2011, p. 150-157.

Research output: Contribution to journalArticle

Battini, R. ; Fogli, A. ; Borghetti, D. ; Michelucci, A. ; Perazza, S. ; Baldinotti, F. ; Conidi, M. E. ; Ferreri, M. I. ; Simi, P. ; Cioni, G. / Clinical and genetic findings in a series of Italian children with pure hereditary spastic paraplegia. In: European Journal of Neurology. 2011 ; Vol. 18, No. 1. pp. 150-157.
@article{c498ba63ada244499d7faacd594fe2a5,
title = "Clinical and genetic findings in a series of Italian children with pure hereditary spastic paraplegia",
abstract = "Background: Hereditary spastic paraplegias (HSP) are a group of neurodegenerative disorders characterized by progressive lower extremity spastic weakness. SPG7, SPG4 and SPG3A are some of the autosomal genes recently found as mutated in recessive or dominant forms of HSP in childhood. SPG31 is more often associated with a pure spastic paraplegia phenotype, but genotype-phenotype correlation is still unclear. The aims of the current study was: (i) to verify the mutational frequency of SPG4, SPG3A, SPG31 and SPG7 genes in our very-well-selected childhood sample, and (ii) to improve our knowledge about the clinical and electrophysiological HSP phenotypes and their possible correlation with a specific mutation.Methods: A sample of 14 Italian children affected by pure HSP (mean age at diagnosis 5.9 years) was extensively investigated with electrophysiological, neuroradiological and genetic tests.Results: Three SPG4 mutations were identified in three patients: two novel missense mutations, both sporadic, and one multiexonic deletion already reported. A novel large deletion in SPG31 gene involving exons 2-5 was also detected in one young patient. No mutations in the SPG7 and in the SPG3A genes were found.Conclusions: Our data confirm that HSP represent a heterogeneous group of genetic neurodegenerative disorders, also in sporadic or autosomal recessive early onset forms. Multiplex Ligation-dependent Probe Amplification-based mutation screening for SPG4 and SPG31 genes would be added to sequencing-based screening of SPG4, SPG31 and SPG3A genes in the routine diagnosis of HSP children.",
keywords = "Evoked potentials, Gene alterations, Pure spastic paraplegia, Transcranial magnetic stimulation",
author = "R. Battini and A. Fogli and D. Borghetti and A. Michelucci and S. Perazza and F. Baldinotti and Conidi, {M. E.} and Ferreri, {M. I.} and P. Simi and G. Cioni",
year = "2011",
month = "1",
doi = "10.1111/j.1468-1331.2010.03102.x",
language = "English",
volume = "18",
pages = "150--157",
journal = "European Journal of Neurology",
issn = "1351-5101",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "1",

}

TY - JOUR

T1 - Clinical and genetic findings in a series of Italian children with pure hereditary spastic paraplegia

AU - Battini, R.

AU - Fogli, A.

AU - Borghetti, D.

AU - Michelucci, A.

AU - Perazza, S.

AU - Baldinotti, F.

AU - Conidi, M. E.

AU - Ferreri, M. I.

AU - Simi, P.

AU - Cioni, G.

PY - 2011/1

Y1 - 2011/1

N2 - Background: Hereditary spastic paraplegias (HSP) are a group of neurodegenerative disorders characterized by progressive lower extremity spastic weakness. SPG7, SPG4 and SPG3A are some of the autosomal genes recently found as mutated in recessive or dominant forms of HSP in childhood. SPG31 is more often associated with a pure spastic paraplegia phenotype, but genotype-phenotype correlation is still unclear. The aims of the current study was: (i) to verify the mutational frequency of SPG4, SPG3A, SPG31 and SPG7 genes in our very-well-selected childhood sample, and (ii) to improve our knowledge about the clinical and electrophysiological HSP phenotypes and their possible correlation with a specific mutation.Methods: A sample of 14 Italian children affected by pure HSP (mean age at diagnosis 5.9 years) was extensively investigated with electrophysiological, neuroradiological and genetic tests.Results: Three SPG4 mutations were identified in three patients: two novel missense mutations, both sporadic, and one multiexonic deletion already reported. A novel large deletion in SPG31 gene involving exons 2-5 was also detected in one young patient. No mutations in the SPG7 and in the SPG3A genes were found.Conclusions: Our data confirm that HSP represent a heterogeneous group of genetic neurodegenerative disorders, also in sporadic or autosomal recessive early onset forms. Multiplex Ligation-dependent Probe Amplification-based mutation screening for SPG4 and SPG31 genes would be added to sequencing-based screening of SPG4, SPG31 and SPG3A genes in the routine diagnosis of HSP children.

AB - Background: Hereditary spastic paraplegias (HSP) are a group of neurodegenerative disorders characterized by progressive lower extremity spastic weakness. SPG7, SPG4 and SPG3A are some of the autosomal genes recently found as mutated in recessive or dominant forms of HSP in childhood. SPG31 is more often associated with a pure spastic paraplegia phenotype, but genotype-phenotype correlation is still unclear. The aims of the current study was: (i) to verify the mutational frequency of SPG4, SPG3A, SPG31 and SPG7 genes in our very-well-selected childhood sample, and (ii) to improve our knowledge about the clinical and electrophysiological HSP phenotypes and their possible correlation with a specific mutation.Methods: A sample of 14 Italian children affected by pure HSP (mean age at diagnosis 5.9 years) was extensively investigated with electrophysiological, neuroradiological and genetic tests.Results: Three SPG4 mutations were identified in three patients: two novel missense mutations, both sporadic, and one multiexonic deletion already reported. A novel large deletion in SPG31 gene involving exons 2-5 was also detected in one young patient. No mutations in the SPG7 and in the SPG3A genes were found.Conclusions: Our data confirm that HSP represent a heterogeneous group of genetic neurodegenerative disorders, also in sporadic or autosomal recessive early onset forms. Multiplex Ligation-dependent Probe Amplification-based mutation screening for SPG4 and SPG31 genes would be added to sequencing-based screening of SPG4, SPG31 and SPG3A genes in the routine diagnosis of HSP children.

KW - Evoked potentials

KW - Gene alterations

KW - Pure spastic paraplegia

KW - Transcranial magnetic stimulation

UR - http://www.scopus.com/inward/record.url?scp=78650127263&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650127263&partnerID=8YFLogxK

U2 - 10.1111/j.1468-1331.2010.03102.x

DO - 10.1111/j.1468-1331.2010.03102.x

M3 - Article

C2 - 20550563

AN - SCOPUS:78650127263

VL - 18

SP - 150

EP - 157

JO - European Journal of Neurology

JF - European Journal of Neurology

SN - 1351-5101

IS - 1

ER -